DFE Pharma, a global provider in pharma- and nutraceutical excipient solutions, launched its new Center of Excellence “Closer to the Formulator” (C2F) in Hyderabad, India. The C2F center aims to help pharmaceutical companies to shorten the time from a concept to a finished commercial product through expertise in all phases of pharmaceutical development.
 
With its ‘First-time right’ formulations, the company aims to address challenges, such as developing robust formulations that can be scaled up for high-speed production, and to support smooth regulatory processes. 
 
The services offered are mainly focused on oral solid dosage forms, comprising all types of pre-registration work including development, scale-up, and technology transfer. Formulation support includes specialized dosage forms such as orally disintegrating, effervescent, chewable, and sublingual tablets, minitablets, etc. C2F capabilities also support efficiency projects such as conversion from wet granulation to direct compression.
 
The center works with the active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs. The equipment covers an instrumented tablet press, an automated capsule filling machine, a tablet coater, a blister packaging machine, stability chambers, and state-of-the-art analytical equipment. 
 
“Our new 1200m2 C2F center of excellence offers cutting-edge capabilities and resources to improve product development globally, while also integrating hardware and data management software,” explains Dr. Anilkumar S. Gandhi, Director of the C2F center.  “Our services result in robust formulations, utilizing top-level excipient expertise transferrable to scale-up. We aim to further collaborate with our customers in this new center to combine the joint formulation expertise.”